Detalles de la búsqueda
1.
Prolonged complete response after treatment withdrawal in HER2-overexpressed, hormone receptor-negative breast cancer with liver metastases: the prospect of disappearance of an incurable disease.
BMC Cancer
; 14: 690, 2014 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-25241752
2.
Understanding Inequalities in the Uptake of Supportive Care to Improve Practices in the Cancer Care Continuum.
Cancers (Basel)
; 14(24)2022 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551539
3.
Psychometric properties of a pictorial instrument for assessing psychopathology in youth aged 12 to 15 years: the Dominic Interactive for Adolescents.
Can J Psychiatry
; 55(4): 211-21, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20416144
4.
Cross-Cultural Adaptation and Psychometric Validation of the French Version of the FAMCARE-Patient (FFP-16) Questionnaire for Outpatients With Advanced-Stage Cancer.
J Pain Symptom Manage
; 60(1): 94-100.e1, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32088357
5.
Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study.
EClinicalMedicine
; 28: 100566, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33205032
6.
[Medico-economic benefits of subcutaneous formulations of trastuzumab and rituximab in day hospitalisation (SCuBA Study)]. / Bénéfices médicoéconomiques des formes sous-cutanées de trastuzumab et de rituximab en hospitalisation de jour (étude SCuBA).
Bull Cancer
; 105(10): 862-872, 2018 Oct.
Artículo
en Francés
| MEDLINE | ID: mdl-30244982
7.
SK3 Gene Polymorphism Is Associated with Taxane Neurotoxicity and Cell Calcium Homeostasis.
Clin Cancer Res
; 24(21): 5313-5320, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30037821
Resultados
1 -
7
de 7
1
Próxima >
>>